Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_assertion description "[A2M, LRP1 (encoding the alpha-2M receptor) and the genes for two other LRP ligands, APOE and APP (encoding the amyloid beta-protein precursor), have now all been genetically linked to AD, suggesting that these proteins may participate in a common neuropathogenic pathway leading to AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_assertion evidence source_evidence_literature NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_assertion SIO_000772 9697696 NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_assertion wasDerivedFrom befree-20150227 NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_assertion wasGeneratedBy ECO_0000203 NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.
- befree-20150227 importedOn "2015-02-27" NP833027.RAV4eldqCvycM81CBoIxMa06GL8zIgQLaH_XG3uC68t2M130_provenance.